IDELALISIB vs IFOSFAMIDE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
IDELALISIB vs IFOSFAMIDE: Safety Overview
| Metric | IDELALISIB | IFOSFAMIDE |
|---|---|---|
| Total FAERS Reports | 6,862 | 17,004 |
| Deaths Reported | 1,548 | 3,365 |
| Death Rate | 22.6% | 19.8% |
| Hospitalizations | 2,962 | 5,230 |
| Average Patient Age | 70.0 yrs | 36.2 yrs |
| % Female Patients | 38.4% | 41.7% |
| FDA Approval Date | Jul 23, 2014 | Apr 4, 2007 |
| Manufacturer | Gilead Sciences, Inc. | Baxter Healthcare Corporation |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Prescription | Prescription |